aTIV

aTIV (adjuvanted Trivalent Influenza Vaccine) is an influenza vaccine that includes the MF59 adjuvant. It is designed to provide a more immunogenic and effective response compared to conventional influenza vaccines, particularly in elderly individuals and children. The vaccine targets various influenza virus strains, such as A/H1N1, A/H3N2, and B strains, to prevent influenza infection and related complications. It has been approved in Europe for adults aged 65 years and over and has been extensively studied for its safety and immunogenicity in different age groups, including infants and young children.

Brand names

FluadGripguardChiromas

Other names

adjuvanted Trivalent Influenza VaccineMF59-adjuvanted trivalent influenza vaccineMF-59-adjuvanted trivalent influenza vaccineMF 59-adjuvanted trivalent influenza vaccine